Tgf-β-activated kinase 1 is crucial in podocyte differentiation and glomerular capillary formation

Journal of the American Society of Nephrology

Volumn 25, Issue 9, 2014, Pages 1966-1978

  Kim, Sung Il ^a,b   Lee, So Young ^a,c   Wang, Zhibo ^a   Ding, Yan ^a,b   Haque, Nadeem ^a   Zhang, Jiwang ^d   Zhou, Jing ^a   Choi, Mary E ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c CHA University   (South Korea)

^d LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; NEPHRIN; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; VASCULOTROPIN; WT1 PROTEIN; MAP KINASE KINASE KINASE 7; MEMBRANE PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; GLOMERULOSCLEROSIS; GLOMERULUS; GLOMERULUS CAPILLARY; HUMAN; HUMAN CELL; IN VIVO STUDY; MESANGIUM; MOUSE; NEWBORN; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEINURIA; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; CAPILLARY; CYTOLOGY; DEFICIENCY; ENZYMOLOGY; FEMALE; GENETICS; GLOMERULAR FILTRATION BARRIER; GROWTH, DEVELOPMENT AND AGING; KNOCKOUT MOUSE; MALE; METABOLISM; PHYSIOLOGY; PREGNANCY; VASCULARIZATION;

ANIMALS; ANIMALS, NEWBORN; CAPILLARIES; CELL DIFFERENTIATION; COLLAGEN; FEMALE; GLOMERULAR FILTRATION BARRIER; KIDNEY GLOMERULUS; MALE; MAP KINASE KINASE KINASES; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PODOCYTES; PREGNANCY; PROTEINURIA; RNA, MESSENGER; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WT1 PROTEINS;

EID: 84921673692     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013030252     Document Type: Article

References (70)

1. Yamaguchi K, Shirakabe K, Shibuya H, Irie K,Oishi I, Ueno N, Taniguchi T, Nishida E, Matsumoto K: Identification of amember of theMAPKKK family as a potential mediator of TGF-beta signal transduction. Science 270: 2008-2011, 1995
2. Shim JH, Greenblatt MB, Xie M, Schneider MD, Zou W, Zhai B, Gygi S, Glimcher LH: TAK1 is an essential regulator of BMP signalling in cartilage. EMBO J 28: 2028-2041, 2009
3. Yamaguchi K, Nagai S, Ninomiya-Tsuji J, Nishita M, Tamai K, Irie K, Ueno N,Nishida E, Shibuya H,Matsumoto K: XIAP, a cellularmember of the inhibitor of apoptosis protein family, links the receptors to TAB1-TAK1 in the BMP signaling pathway. EMBO J 18: 179-187, 1999
4. Sakurai H, Suzuki S, Kawasaki N, Nakano H, Okazaki T, Chino A, Doi T, Saiki I: Tumor necrosis factor-alpha-induced IKK phosphorylation of NF-kappaB p65 on serine 536 is mediated through the TRAF2, TRAF5, and TAK1 signaling pathway. J Biol Chem 278: 36916-36923, 2003
5. Ninomiya-Tsuji J, Kishimoto K, Hiyama A, Inoue J, Cao Z,Matsumoto K: The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature 398: 252-256, 1999
6. Irie T, Muta T, Takeshige K: TAK1 mediates an activation signal from toll-like receptor(s) to nuclear factor-kappaB in lipopolysaccharidestimulated macrophages. FEBS Lett 467: 160-164, 2000
7. Shirakabe K, Yamaguchi K, Shibuya H, Irie K, Matsuda S, Moriguchi T, Gotoh Y, Matsumoto K, Nishida E: TAK1 mediates the ceramide signaling to stress-activated protein kinase/c-Jun N-terminal kinase. J Biol Chem 272: 8141-8144, 1997
8. Ishitani T, Kishida S, Hyodo-Miura J, Ueno N, Yasuda J, Waterman M, Shibuya H, Moon RT, Ninomiya-Tsuji J, Matsumoto K: The TAK1-NLK mitogen-activated protein kinase cascade functions in theWnt-5a/Ca(2 +) pathway to antagonizeWnt/beta-catenin signaling. Mol Cell Biol 23:131-139, 2003
9. Singhirunnusorn P, Suzuki S, Kawasaki N, Saiki I, Sakurai H: Critical roles of threonine 187 phosphorylation in cellular stress-induced rapid and transient activation of transforming growth factor-beta-activated kinase 1 (TAK1) in a signaling complex containing TAK1-binding protein TAB1 and TAB2. J Biol Chem 280: 7359-7368, 2005
10. Xie M, Zhang D, Dyck JR, Li Y, Zhang H, Morishima M, Mann DL, Taffet GE, Baldini A, KhouryDS, SchneiderMD: A pivotal role for endogenous TGF-beta-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathway. Proc Natl Acad Sci U S A 103: 17378-17383, 2006
11. Hallows KR, Mount PF, Pastor-Soler NM, Power DA: Role of the energy sensor AMP-activated protein kinase in renal physiology and disease. Am J Physiol Renal Physiol 298: F1067-F1077, 2010
12. Smit L, Baas A, Kuipers J, Korswagen H, van deWetering M, Clevers H: Wnt activates the Tak1/Nemo-like kinase pathway. J Biol Chem 279: 17232-17240, 2004
13. Pulkkinen K,Murugan S, Vainio S:Wnt signaling in kidney development and disease. Organogenesis 4: 55-59, 2008
14. Wang D, Dai C, Li Y, Liu Y: CanonicalWnt/b-catenin signalingmediates transforming growth factor-b1-driven podocyte injury and proteinuria. Kidney Int 80: 1159-1169, 2011
15. Dai C, Stolz DB, Kiss LP,Monga SP, Holzman LB, Liu Y: Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria. J Am Soc Nephrol 20: 1997-2008, 2009
16. Chapin HC, Caplan MJ: The cell biology of polycystic kidney disease. J Cell Biol 191: 701-710, 2010
17. Salmon AH, Neal CR, Harper SJ: New aspects of glomerular filtration barrier structure and function: Five layers (at least) not three. Curr Opin Nephrol Hypertens 18: 197-205, 2009
18. Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, Housman D, Jaenisch R: WT-1 is required for early kidney development. Cell 74: 679-691, 1993
19. Moore AW, McInnes L, Kreidberg J, Hastie ND, Schedl A: YAC complementation shows a requirement for Wt1 in the development of epicardium, adrenal gland and throughout nephrogenesis. Development 126: 1845-1857, 1999
20. Chen H, Lun Y,Ovchinnikov D, Kokubo H,Oberg KC, Pepicelli CV, Gan L, Lee B, Johnson RL: Limb and kidney defects in Lmx1b mutant mice suggest an involvement of LMX1B in human nail patella syndrome. Nat Genet 19: 51-55, 1998
21. Rohr C, Prestel J, Heidet L, Hosser H, Kriz W, Johnson RL, Antignac C, Witzgall R: The LIM-homeodomain transcription factor Lmx1b plays a crucial role in podocytes. J Clin Invest 109: 1073-1082, 2002
22. Cui S, Li C, Ema M, Weinstein J, Quaggin SE: Rapid isolation of glomeruli coupled with gene expression profiling identifies downstream targets in Pod1 knockoutmice. J AmSoc Nephrol 16: 3247-3255, 2005
23. Quaggin SE, Schwartz L, Cui S, Igarashi P, Deimling J, Post M, Rossant J: The basic-helix-loop-helix protein pod1 is critically important for kidney and lung organogenesis. Development 126: 5771-5783, 1999
24. Kreidberg JA:WT1 and kidney progenitor cells. Organogenesis 6: 61-70, 2010
25. Tryggvason K, Patrakka J, Wartiovaara J: Hereditary proteinuria syndromes and mechanisms of proteinuria.N Engl J Med 354: 1387-1401, 2006
26. Wolf G, Ziyadeh FN: Cellular and molecular mechanisms of proteinuria in diabetic nephropathy. Nephron Physiol 106: 26-31, 2007
27. Reidy K, Susztak K: Epithelial-mesenchymal transition and podocyte loss in diabetic kidney disease. Am J Kidney Dis 54: 590-593, 2009
28. Yamaguchi Y, IwanoM, SuzukiD,Nakatani K, Kimura K, Harada K, Kubo A, Akai Y, Toyoda M, Kanauchi M, Neilson EG, Saito Y: Epithelialmesenchymal transition as a potential explanation for podocyte depletion in diabetic nephropathy. Am J Kidney Dis 54: 653-664, 2009
29. Woolard J, Wang WY, Bevan HS, Qiu Y, Morbidelli L, Pritchard-Jones RO, Cui TG, Sugiono M, Waine E, Perrin R, Foster R, Digby-Bell J, Shields JD, Whittles CE, Mushens RE, Gillatt DA, Ziche M, Harper SJ, Bates DO: VEGF165b, an inhibitory vascular endothelial growth factor splice variant: Mechanism of action, in vivo effect on angiogenesis and endogenous protein expression. Cancer Res 64: 7822-7835, 2004
30. Konopatskaya O, Churchill AJ, Harper SJ, Bates DO, Gardiner TA: VEGF165b, an endogenous C-terminal splice variant of VEGF, inhibits retinal neovascularization in mice. Mol Vis 12: 626-632, 2006
31. Simon M, Gröne HJ, Jöhren O, Kullmer J, Plate KH, Risau W, Fuchs E: Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney. Am J Physiol 268: F240-F250, 1995
32. Eremina V, Sood M, Haigh J, Nagy A, Lajoie G, Ferrara N, Gerber HP, Kikkawa Y, Miner JH, Quaggin SE: Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 111: 707-716, 2003
33. Eremina V,Cui S,GerberH, FerraraN,Haigh J,Nagy A, EmaM, Rossant J, Jothy S, Miner JH, Quaggin SE: Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival. J Am SocNephrol 17: 724-735, 2006
34. Sugimoto H, Hamano Y, Charytan D, Cosgrove D, Kieran M, Sudhakar A, Kalluri R: Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem 278: 12605-12608, 2003
35. Frangié C, Lefaucheur C, Medioni J, Jacquot C, Hill GS,NochyD: Renal thrombotic microangiopathy caused by anti-VEGF-antibody treatment for metastatic renal-cell carcinoma. Lancet Oncol 8: 177-178, 2007
36. Eremina V, Jefferson JA, Kowalewska J, Hochster H,HaasM,Weisstuch J, Richardson C, Kopp JB, Kabir MG, Backx PH, Gerber HP, Ferrara N, Barisoni L, Alpers CE, Quaggin SE: VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 358: 1129-1136, 2008
37. Veron D, Reidy KJ, Bertuccio C, Teichman J, Villegas G, Jimenez J, Shen W, Kopp JB, Thomas DB, Tufro A: Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease. Kidney Int 77: 989-999, 2010
38. Ruotsalainen V, Ljungberg P, Wartiovaara J, Lenkkeri U, Kestilä M, Jalanko H, Holmberg C, Tryggvason K: Nephrin is specifically located at the slit diaphragmof glomerular podocytes. ProcNatl Acad Sci U S A 96: 7962-7967, 1999
39. Lenkkeri U, Männikkö M, McCready P, Lamerdin J, Gribouval O, Niaudet PM, AntignacCK, Kashtan CE,Homberg C,Olsen A, KestiläM, Tryggvason K: Structure of the gene for congenital nephrotic syndrome of the finnish type (NPHS1) and characterization of mutations. Am J Hum Genet 64: 51-61, 1999
40. Gagliardini E, Benigni A, Tomasoni S, Abbate M, Kalluri R, Remuzzi G: Targeted downregulation of extracellular nephrin in human IgA nephropathy. Am J Nephrol 23: 277-286, 2003
41. Toyoda M, Suzuki D, Umezono T, Uehara G, Maruyama M, Honma M, Sakai T, Sakai H: Expression of human nephrin mRNA in diabetic nephropathy. Nephrol Dial Transplant 19: 380-385, 2004
42. GuoG,MorrisonDJ, Licht JD,Quaggin SE:WT1 activates a glomerularspecific enhancer identified from the human nephrin gene. J Am Soc Nephrol 15: 2851-2856, 2004
43. WagnerN,Wagner KD, Xing Y, Scholz H, Schedl A: Themajor podocyte protein nephrin is transcriptionally activated by the Wilms tumor suppressor WT1. J Am Soc Nephrol 15: 3044-3051, 2004
44. Beltcheva O, Hjorleifsdottir EE, Kontusaari S, Tryggvason K: Sp1 specifically binds to an evolutionarily conserved DNA segment within a region necessary for podocyte-specific expression of nephrin. Nephron Exp Nephrol 114: e15-e22, 2010
45. Matsui I, Ito T, Kurihara H, Imai E, Ogihara T, Hori M: Snail, a transcriptional regulator, represses nephrin expression in glomerular epithelial cells of nephrotic rats. Lab Invest 87: 273-283, 2007
46. Ristola M, Arpiainen S, Saleem MA, Holthöfer H, Lehtonen S: Transcription of nephrin-Neph3 gene pair is synergistically activated by WT1 and NF-kB and silenced by DNA methylation. Nephrol Dial Transplant 27: 1737-1745, 2012
47. Miyazaki Y, Oshima K, Fogo AB, Hogan BL, Ichikawa I: Bone morphogenetic protein 4 regulates the budding site and elongation of the mouse ureter. J Clin Invest 105: 863-873, 2000
48. Moeller MJ, Sanden SK, Soofi A, Wiggins RC, Holzman LB: Podocytespecific expression of cre recombinase in transgenic mice. Genesis 35: 39-42, 2003
49. Liu A, Dardik A, Ballermann BJ: Neutralizing TGF-beta1 antibody infusion in neonatal rat delays in vivo glomerular capillary formation 1. Kidney Int 56: 1334-1348, 1999
50. Ueda H, Miyazaki Y, Matsusaka T, Utsunomiya Y, Kawamura T, Hosoya T, Ichikawa I: Bmp in podocytes is essential for normal glomerular capillary formation. J Am Soc Nephrol 19: 685-694, 2008
51. Freeburg PB, Robert B, St John PL, Abrahamson DR: Podocyte expression of hypoxia-inducible factor (HIF)-1 and HIF-2 during glomerular development. J Am Soc Nephrol 14: 927-938, 2003
52. Cook HT, Tarzi R, DSouza Z, Laurent G, Lin WC, Aitman TJ, Mechta-Grigoriou F,Behmoaras J: AP-1 transcription factor JunDconfers protection from accelerated nephrotoxic nephritis and control podocyte-specific Vegfa expression. Am J Pathol 179: 134-140, 2011
53. Armstrong JF, Pritchard-Jones K, Bickmore WA, Hastie ND, Bard JB: The expression of the Wilms tumour gene, WT1, in the developing mammalian embryo. Mech Dev 40: 85-97, 1993
54. Natoli TA, Liu J, Eremina V, Hodgens K, Li C, Hamano Y, Mundel P, Kalluri R, Miner JH, Quaggin SE, Kreidberg JA: A mutant form of the Wilms tumor suppressor gene WT1 observed in Denys-Drash syndrome interferes with glomerular capillary development. J Am Soc Nephrol 13: 2058-2067, 2002
55. Bollig F, Perner B, Besenbeck B, Köthe S, Ebert C, Taudien S, Englert C: A highly conserved retinoic acid responsive element controls wt1a expression in the zebrafish pronephros.Development 136: 2883-2892, 2009
56. CohenHT,Bossone SA, Zhu G,McDonaldGA, SukhatmeVP: Sp1 is a critical regulator of the Wilms tumor-1 gene. J Biol Chem272: 2901-2913, 1997
57. Furuhata A, Murakami M, Ito H, Gao S, Yoshida K, Sobue S, Kikuchi R, Iwasaki T, Takagi A, Kojima T, Suzuki M, Abe A, Naoe T, Murate T: GATA-1 and GATA-2 binding to 39 enhancer of WT1 gene is essential for its transcription in acute leukemia and solid tumor cell lines. Leukemia 23: 1270-1277, 2009
58. Dehbi M, Hiscott J, Pelletier J: Activation of the wt1 Wilms tumor suppressor gene by NF-kappaB. Oncogene 16: 2033-2039, 1998
59. Kestilä M, Lenkkeri U,Männikkö M, Lamerdin J, McCready P, Putaala H, Ruotsalainen V, Morita T, NissinenM, Herva R, Kashtan CE, Peltonen L, Holmberg C, Olsen A, Tryggvason K: Positionally cloned gene for a novel glomerular protein-nephrin-is mutated in congenital nephrotic syndrome. Mol Cell 1: 575-582, 1998
60. Putaala H, Soininen R, Kilpeläinen P, Wartiovaara J, Tryggvason K: The murine nephrin gene is specifically expressed in kidney, brain and pancreas: Inactivation of the gene leads to massive proteinuria and neonatal death. Hum Mol Genet 10: 1-8, 2001
61. Doné SC, Takemoto M, He L, Sun Y, Hultenby K, Betsholtz C, Tryggvason K: Nephrin is involved in podocyte maturation but not survival during glomerular development. Kidney Int 73: 697-704, 2008
62. Uchida K, Suzuki K, Iwamoto M, Kawachi H, Ohno M, Horita S, Nitta K: Decreased tyrosine phosphorylation of nephrin in rat and human nephrosis. Kidney Int 73: 926-932, 2008
63. Wernerson A, Dunér F, Pettersson E, Widholm SM, Berg U, Ruotsalainen V, Tryggvason K, Hultenby K, Söderberg M: Altered ultrastructural distribution of nephrin in minimal change nephrotic syndrome. Nephrol Dial Transplant 18: 70-76, 2003
64. Reidy K, Tufro A: Semaphorins in kidney development and disease: Modulators of ureteric bud branching, vascular morphogenesis, and podocyte-endothelial crosstalk. Pediatr Nephrol 26: 1407-1412, 2011
65. Reidy KJ, Villegas G, Teichman J, Veron D, Shen W, Jimenez J, Thomas D, Tufro A: Semaphorin3a regulates endothelial cell number and podocyte differentiation during glomerular development. Development 136: 3979-3989, 2009
66. Matsusaka T, Sandgren E, Shintani A, Kon V, Pastan I, Fogo AB, Ichikawa I: Podocyte injury damages other podocytes. J Am Soc Nephrol 22: 1275-1285, 2011
67. Fukuda A, Wickman LT, Venkatareddy MP, Sato Y, Chowdhury MA, Wang SQ, Shedden KA, Dysko RC, Wiggins JE, Wiggins RC: Angiotensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease. Kidney Int 81: 40-55, 2012
68. Kazama I, Mahoney Z, Miner JH, Graf D, Economides AN, Kreidberg JA: Podocyte-derived BMP7 is critical for nephron development. J Am Soc Nephrol 19: 2181-2191, 2008
69. Sato S, Sanjo H, Takeda K, Ninomiya-Tsuji J, Yamamoto M, Kawai T, Matsumoto K, Takeuchi O, Akira S: Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat Immunol 6: 1087-1095, 2005
70. Tang M, Wei X, Guo Y, Breslin P, Zhang S, Zhang S, Wei W, Xia Z, Diaz M, Akira S, Zhang J: TAK1 is required for the survival of hematopoietic cells and hepatocytes in mice. J ExpMed 205: 1611-1619, 2008